Introduction

Myelodysplastic syndrome (MDS) is a heterogeneous group of stem-cell disorders characterized by multi-lineage dysplasia and pancytopenia due to ineffective hematopoiesis (1). Many cases show various types of cytogenetic abnormalities. Trisomy 8 is one of the most frequent abnormalities and occurs at a frequency of 8.9-20% among MDS patients (2). Behçet's disease is a chronic, relapsing, inflammatory disease of unknown etiology characterized by recurrent oral ulcers, genital ulcers and eye and skin lesions. Intestinal lesions occur in approximately 15% of the patients; patients with diffuse intestinal ulcers are very difficult to treat and have higher mortality because of severe complications such as hemorrhage, perforation and infection (3). This disease is considered to occur due to a type of multisystem vasculitis, but the etiology is unknown. The association of these two diseases has been reported in only 28 cases
; most of these had coexistent intestinal Behçet's disease with ulcers of the terminal ileum and without eye lesions (6, 7) . Interestingly, it is speculated that this is not a simple coexistence but that the aetiology of intestinal Behçet's disease is at least partly derived from MDS itself (2, 5, 11, 12 (4, 6, 9 CT s c a n s s h o we d ma r k e d e d e ma o f t h e i l e o c e c u m  r e g i o n ( a r r o ws ) a n d i n f l a mma t i o n o f t h e s u r r o u n d i n g f a t  t i s s u e . dup (1) 
Epithelioid cell granuloma, inclusion bodies of cytomegalovirus (CMV) infection, amoeba and infiltrating blasts were not observed. From these findings, invasion of blasts or viral infection was unlikely as a cause of multiple ulcers. It has been reported that MDS patients complicated with intestinal Behçet's disease often have trisomy 8 (7). Thus, along with recurrent oral aphthae in the past two years, multiple ulcers in this patient were diagnosed as intestinal Behçet's disease. We did not use prednisolone or other immunosuppressive drugs for the treatment of ulcers; instead, we started total parenteral nutrition. Because coagulation tests showed a prolonged activated partial thromboplastin time (APTT) and elevated fibrin degradation products (FDP), dalteparin was used to prevent thrombosis, which has been reported to be increased in MDS patients with trisomy 8 associated with Behçet's disease (9). Barium enema performed after 2 weeks showed little improvement of the ulcers, but there was a longitudinal ulcer at the terminal ileum. The leukocyte count dropped to 0.66 × 10 9 per litre with 15% neutrophils, but G-CSF was not used because it may act as an exacerbating factor for ulcers and thrombosis in MDS patients with trisomy 8 associated with Behçet's disease (9).
In early October, she underwent CBT from an unrelated 
Discussion
The efficacy and feasibility of autologous HSCT for hematological malignancies such as non-Hodgkin lymphoma and multiple myeloma have been established. Recently, it is also used as a new therapy for the treatment of severe autoimmune diseases such as multiple sclerosis, systemic sclerosis and systemic lupus erythematosus (13) (14) (15) . Autologous HSCT has also been performed on three patients with Behçet's disease (16) (17) (18) (2, 5, 11, 12 
